Curofy
Vyome Bio's acne drug gets USFDA nod
Bio-pharmaceutical company Vyome Biosciences today said the US Food and Drug Administration (USFDA) has cleared its investigational new drug (IND) to treat moderate-to-severe acne.
See this content immediately after install